We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.42B
AUM Growth
+$877M
Cap. Flow
-$870M
Cap. Flow %
-16.07%
Top 10 Hldgs %
57.84%
Holding
236
New
154
Increased
21
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
OSCR icon
Oscar Health
OSCR
+$77.6M
2
BAX icon
Baxter International
BAX
+$48.1M
3
RVMD icon
Revolution Medicines
RVMD
+$32.2M
4
SWTX
SpringWorks Therapeutics
SWTX
+$26.2M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$22.9M

Top Sells

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$38.5M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$36M
3
ACH
Accendra Health
ACH
+$21.8M
4
MRUS
Merus
MRUS
+$20M
5
ROIV icon
Roivant Sciences
ROIV
+$18.7M

Sector Composition

Rank Sector Weight
1 Healthcare 78.17%
2 Technology 0.1%
3 Industrials 0.09%
4 Consumer Discretionary 0.08%
5 Consumer Staples 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIM
201
Chimera Investment
CIM
$1.05B
$95.8K ﹤0.01%
+6,402
New +$96.6K
ALLO icon
202
Allogene Therapeutics
ALLO
$604M
$90.4K ﹤0.01%
+28,169
New +$79.9K
OCUL icon
203
Ocular Therapeutix
OCUL
$1.89B
$84.7K ﹤0.01%
+18,987
New +$56.1K
AMPY icon
204
Amplify Energy
AMPY
$155M
$83.5K ﹤0.01%
+14,081
New +$90.9K
GERN icon
205
Geron
GERN
$949M
$75.3K ﹤0.01%
+35,675
New +$69.4K
MDVL
206
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$75.1K ﹤0.01%
16,732
– –
SPWR
207
DELISTED
SunPower Corporation Common Stock
SPWR
$58.3K ﹤0.01%
+12,062
New +$57.6K
SANA icon
208
Sana Biotechnology
SANA
$913M
$51.1K ﹤0.01%
+12,530
New +$46.2K
SKIN icon
209
SkinHealth Systems
SKIN
$96.9M
$47.1K ﹤0.01%
+15,157
New +$56.9K
BFLY.WS
210
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$25.7K ﹤0.01%
733,333
– –
SLGCW
211
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$14.4K ﹤0.01%
120,000
– –
NUVB.WS
212
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$10K ﹤0.01%
166,666
– –
CMAXW
213
DELISTED
CareMax, Inc. Warrant
CMAXW
$5.04K ﹤0.01%
672,000
– –
SRZNW icon
214
Surrozen Inc Warrant
SRZNW
$75.6K
$3.23K ﹤0.01%
166,666
– –
TLSI icon
215
TriSalus Life Sciences
TLSI
$265M
$8 ﹤0.01%
1
– –
BCYC
216
Bicycle Therapeutics
BCYC
$276M
– –
-448,753
Closed -$9.02M
BDTX icon
217
Black Diamond Therapeutics
BDTX
$99.1M
– –
-930,447
Closed -$2.67M
CRBU icon
218
Caribou Biosciences
CRBU
$158M
– –
-3,500,000
Closed -$16.7M
DNLI icon
219
Denali Therapeutics
DNLI
$3.74B
– –
-594,989
Closed -$12.3M
FDMT icon
220
4D Molecular Therapeutics
FDMT
$543M
– –
-650,000
Closed -$8.27M
FHTX icon
221
Foghorn Therapeutics
FHTX
$305M
– –
-777,525
Closed -$3.89M
LUNG icon
222
Pulmonx
LUNG
$51.5M
– –
-1,017,958
Closed -$10.5M
ROIV icon
223
Roivant Sciences
ROIV
$25B
– –
-1,604,487
Closed -$18.7M
TARS icon
224
Tarsus Pharmaceuticals
TARS
$2.62B
– –
-754,042
Closed -$13.4M
CUTR
225
DELISTED
Cutera, Inc.
CUTR
– –
-154,406
Closed -$930K
6 7 8
9
10

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2023 Portfolio in Review

As of Q4 2023, Deerfield Management held 236 positions worth $5.42B, up 19% from $4.54B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Deerfield Management withdrew a net $870M in Q4 2023, closing 14 positions and reducing 12 holdings. Its most notable exit was Intercept Pharmaceuticals, Inc., an estimated $38.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 68% a quarter earlier, followed by Technology and Industrials.

Against the trend, Deerfield Management opened a new position in Oscar Health worth $103M.

  • Deerfield Management's largest Q4 2023 buy was Oscar Health: 11,246,820 shares worth $103M.
  • Deerfield Management added most to Revolution Medicines in Q4 2023, an estimated $32.2M increase.
  • Deerfield Management's biggest Q4 2023 reduction was Neurocrine Biosciences, cutting an estimated $36M.
  • Deerfield Management fully exited Intercept Pharmaceuticals, Inc. in Q4 2023, selling an estimated $38.5M.
  • Deerfield Management's ten largest holdings make up 58% of its $5.42B portfolio in Q4 2023.
  • Deerfield Management opened 154 new positions and closed 14 in Q4 2023.
  • Deerfield Management's portfolio value rose 19% quarter-over-quarter to $5.42B.

Based on Deerfield Management's 13F filing for Q4 2023, filed 14 Feb 2024.